Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?

Deng, Jie-Lin; Jiang, Yun-Qiu; Guo, Yan-Kai; Li, Hong-Liang

Deng, Jie-Lin; Jiang, Yun-Qiu; Guo, Yan-Kai; Li, Hong-Liang.

Deng JL; Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei 430060, China.
Jiang YQ; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Guo YK; Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Li HL; Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei 430060, China.

Chin Med J (Engl) ; 133(22): 2650-2652, 2020 11 20.

Article in English | MEDLINE | ID: covidwho-721895

Subject(s)

Angiotensin II Type 1 Receptor Blockers/adverse effects; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Betacoronavirus; Coronavirus Infections/etiology; Pneumonia, Viral/etiology; Angiotensin-Converting Enzyme 2; COVID-19; Humans; Pandemics; Peptidyl-Dipeptidase A/physiology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Angiotensin-Converting Enzyme Inhibitors / Coronavirus Infections / Angiotensin II Type 1 Receptor Blockers / Betacoronavirus Type of study: Prognostic study Limits: Humans Language: English Journal: Chin Med J (Engl) Year: 2020 Document Type: Article Affiliation country: CM9.0000000000000996

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google